Commonwealth Equity Services’s Cytokinetics CYTK Stock Holding History

Commonwealth Equity Services’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$404K	Sell	4,746 -111	-2%	-$7.97K	﹤0.01%	3485
2026 Q1	$320K	Buy	4,857 +12	+0.2%	+$763	﹤0.01%	3609
2025 Q4	$308K	Sell	4,845 -287	-6%	-$17.9K	﹤0.01%	3630
2025 Q3	$282K	Buy	+5,132	New	+$211K	﹤0.01%	3705
2015 Q2	–	Sell	-15,092	Closed	-$102K	–	2208
2015 Q1	$102K	Buy	+15,092	New	+$113K	﹤0.01%	2056

Other funds holding CYTK

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Commonwealth Equity Services's CYTK Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Cytokinetics (CYTK) stake by 2.3% in Q2 2026, selling an estimated $7.97K and leaving 4,746 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #3485.

Commonwealth Equity Services first reported a position in CYTK in Q1 2015 and has held it in 5 quarters since. 105 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Commonwealth Equity Services held 4,746 shares of Cytokinetics worth $404K as of Q2 2026.
Commonwealth Equity Services sold 111 Cytokinetics shares in Q2 2026, an estimated $7.97K.
Cytokinetics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3485 holding.
Commonwealth Equity Services first reported a position in Cytokinetics in Q1 2015 and has held it in 5 quarters since.
105 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.